NEW YORK (360Dx) – Australian proteomics firm Proteomics International Laboratories said today it has licensed its PromarkerD test for diabetic kidney disease to Patia BioPharma for commercialization in Mexico.

According to Proteomics International, Patia will develop and commercialize PromarkerD as a mass spec-based laboratory-developed test performed by its partner, Clinica Ruiz Laboratories.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease. 

Sponsored by

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.